Nail toxicity related to weekly taxanes: an important issue requiring a change in common toxicity criteria grading?
Spazzapan
Simon
S
Crivellari
Diana
D
Lombardi
Davide
D
Scuderi
Cristina
C
Magri
Maria Donatella
MD
Veronesi
Andrea
A
Gatti
Alessandro
A
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D006801:Humans; D009260:Nail Diseases / Q000139:chemically induced* / Q000473:pathology; D017239:Paclitaxel / Q000009:adverse effects* / Q000627:therapeutic use; D010858:Pigmentation; D011788:Quality of Life; D012720:Severity of Illness Index
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel